Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Statera Biopharma, Inc. STAB

Set alert

Price alert · STAB

All alert types
0.00 USD 0.00 0.00%

At close · Oct 30

0.0001 Day range 0.0001
0.0001 52-week range 0.0266
YTD
-66.67%
1 year
0.00%
Open
0.0001
Prev close
0.0001
Mkt cap
7.14K
Vol
700
Avg vol
25.02K
EPS
-0.39
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0001
High
0.0001
Forward P/E
0.00
Beta
0.00
Short ratio
0.39
Inst. own
5.03%
Dividend
0.00
Ex-div date
Earnings
Jan 1, 2024
50-d avg
0.076158
200-d avg
0.168793
1y target
0.00

3M chart

Chart tools
Interval
1m5m15m30m

Signals (17)
NameDateAgo
SMA: BearishOct 23, 20261 week ago
SMA: BearishOct 23, 20261 week ago
SMA: BullishOct 22, 20261 week ago
SMA: BullishOct 22, 20261 week ago
RSI: OverboughtOct 22, 20261 week ago
MACD: Buy SignalOct 12, 20263 weeks ago
SMA: BearishSep 18, 20261 month ago
SMA: BearishSep 18, 20261 month ago
MACD: Sell SignalSep 18, 20261 month ago
MACD: Buy SignalSep 1, 20262 months ago
SMA: BullishAug 31, 20262 months ago
SMA: BullishAug 31, 20262 months ago
SMA: BearishAug 18, 20262 months ago
SMA: BearishAug 18, 20262 months ago
MACD: Sell SignalAug 18, 20262 months ago
SMA: BullishAug 5, 20262 months ago
SMA: BullishAug 5, 20262 months ago

Financial health

Altman Z-Score

-22.79 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.5×
FY 2012: -0.0×FY 2013: -0.0×FY 2014: 8.3×FY 2015: -2.8×FY 2016: -20.9×FY 2017: -5.8×FY 2018: -15.7×FY 2019: -38.5×FY 2020: -9.6×FY 2021: -0.5×
FY 2012 5y median -9.6× FY 2021
P/S 0.0×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2012 5y median 0.0× FY 2021
P/B -51.5×
FY 2012: 0.0×FY 2013: -0.0×FY 2014: -13.5×FY 2015: 3.6×FY 2016: 7.3×FY 2017: 25.5×FY 2018: -39.0×FY 2019: -30.5×FY 2020: -35.2×FY 2021: -51.5×
FY 2012 5y median -35.2× FY 2021
P/FCF -2.8×
FY 2012: -0.0×FY 2013: -0.0×FY 2014: -0.9×FY 2015: -2.9×FY 2016: -10.9×FY 2017: -8.5×FY 2018: -12.3×FY 2019: -535×FY 2020: -25.2×FY 2021: -2.8×
FY 2012 5y median -12.3× FY 2021
EV/EBITDA -0.6×
FY 2012: 1.4×FY 2013: 0.2×FY 2014: 26.2×FY 2015: -2.3×FY 2016: -7.6×FY 2017: -9.3×FY 2018: -11.0×FY 2019: -42.2×FY 2020: -11.9×FY 2021: -0.6×
FY 2012 5y median -11.0× FY 2021
EV/Sales 0.0×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2012 5y median 0.0× FY 2021
FCF Yield -35.1%
FY 2012: -10214.0%FY 2013: -9705.0%FY 2014: -106.7%FY 2015: -34.2%FY 2016: -9.2%FY 2017: -11.8%FY 2018: -8.2%FY 2019: -0.2%FY 2020: -4.0%FY 2021: -35.1%
FY 2012 5y median -8.2% FY 2021

Profitability

Gross Margin 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Operating Margin 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Net Margin 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
ROE 11122.7%
FY 2012: -287.9%FY 2013: 181.3%FY 2014: -162.3%FY 2015: -127.8%FY 2016: -35.3%FY 2017: -441.3%FY 2018: 248.8%FY 2019: 79.5%FY 2020: 361.7%FY 2021: 11122.7%
FY 2012 5y median 248.8% FY 2021
ROIC -666.5%
FY 2012: -145.5%FY 2013: -262.4%FY 2014: -228.1%FY 2015: -71.8%FY 2016: -49.0%FY 2017: -75.1%FY 2018: -132.5%FY 2019: -880.1%FY 2020: 635.6%FY 2021: -666.5%
FY 2012 5y median -132.5% FY 2021
ROA -823.9%
FY 2012: -57.0%FY 2013: -117.5%FY 2014: 45.9%FY 2015: -60.5%FY 2016: -16.7%FY 2017: -100.8%FY 2018: -79.7%FY 2019: -202924.5%FY 2020: -1277.1%FY 2021: -823.9%
FY 2012 5y median -823.9% FY 2021

Growth (YoY)

Revenue 0.0%
FY 2012: -100.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 FY 2021
Operating Income -836.5%
FY 2012: -19.7%FY 2013: 23.2%FY 2014: 37.5%FY 2015: 99.9%FY 2016: 41.1%FY 2017: 11.9%FY 2018: 14.3%FY 2019: 41.4%FY 2020: -273.2%FY 2021: -836.5%
FY 2012 FY 2021
EPS (diluted) -855.8%
FY 2012: -312.3%FY 2013: 19.6%FY 2014: 100.2%FY 2015: -398.3%FY 2016: 86.6%FY 2017: -262.5%FY 2018: 63.2%FY 2019: 59.4%FY 2020: -300.0%FY 2021: -855.8%
FY 2012 FY 2021
Free Cash Flow -457.3%
FY 2012: -22.1%FY 2013: -11.9%FY 2014: 37.4%FY 2015: 99.9%FY 2016: 58.3%FY 2017: -31.2%FY 2018: 30.2%FY 2019: 94.8%FY 2020: -2018.3%FY 2021: -457.3%
FY 2012 FY 2021

Financial Health

Current Ratio 0.4×
FY 2012: 2.6×FY 2013: 1.9×FY 2014: -1.2×FY 2015: 3.5×FY 2016: 5.1×FY 2017: 4.3×FY 2018: 4.9×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 0.4×
FY 2012 5y median 0.4× FY 2021
Quick Ratio 0.4×
FY 2012: 2.6×FY 2013: 1.9×FY 2014: -1.2×FY 2015: 3.5×FY 2016: 5.1×FY 2017: 4.3×FY 2018: 4.9×FY 2019: 0.3×FY 2020: 0.2×FY 2021: 0.4×
FY 2012 5y median 0.4× FY 2021
Debt / Equity -10.4×
FY 2012: 0.0×FY 2013: -0.8×FY 2014: -7.3×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.4×FY 2020: -0.5×FY 2021: -10.4×
FY 2012 5y median -0.4× FY 2021
Net Debt / EBITDA -0.1×
FY 2012: 1.4×FY 2013: 0.2×FY 2014: 7.9×FY 2015: 0.5×FY 2016: 1.1×FY 2017: 0.8×FY 2018: 0.8×FY 2019: -0.6×FY 2020: -0.1×FY 2021: -0.1×
FY 2012 5y median -0.1× FY 2021
Interest Coverage -76.4×
FY 2012: 429×FY 2013: -278×FY 2014: 13.2×FY 2015: 108×FY 2016: -24.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -22.7×FY 2020: -9.3×FY 2021: -76.4×
FY 2012 5y median -9.3× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31